About
Technology
Issues
FAQ
Links
Official Page
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.